Picture Berlin Partner Bionnale 2021 Digital Event 650x80px
Collaboration › Details

Bruker–Cowen: investor conference, 201903 supply service Bruker presents at Cowen & Co Annual Health Care Conference 2019


Period Period 2019-03-12
Region Region Boston, MA
  Country United States (USA)
Organisations Partner, 1st Bruker Corporation (Nasdaq: BRKR)
  Group Bruker (Group)
  Partner, 2nd Cowen & Company LLC
  Group Cowen (Group)
Products Product Cowen & Co. Annual Health Care Conference 2019 Boston
  Product 2 analytical instrument
Persons Person Herman, Gerald N. (Bruker Corp 201806– CFO before Interim CFO joined 12/16 as VP + Corp Controller before Parexel)
  Person 2 Minkova, Miroslava (Bruker Corp 201611 Head of Investor Relations)

Bruker Corporation. (2/25/19). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA.

Bruker Corporation (Nasdaq: BRKR) announced today it will present at the following conferences:

8th Annual SVB Leerink Healthcare Conference, New York, NY
Thursday, February 28, 2019, at 10:30 a.m. Eastern Time
Frank Laukien, Chairman, President and Chief Executive Officer

Cowen 39th Annual Health Care Conference, Boston, MA
Tuesday, March 12, 2019, at 10:40 a.m. Eastern Time
Gerald Herman, Chief Financial Officer

Barclays Global Healthcare Conference, Miami Beach, FL
Thursday, March 14, 2019, at 10:45 a.m. Eastern Time
Frank Laukien, Chairman, President and Chief Executive Officer

Live audio webcasts of the presentations will be available on the Investor Relations section of the Company's website at Replays will be posted on the Bruker Corporation Investor Relations website after each event and will be available for 30 days following the presentation.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit:

Contact :

Miroslava Minkova
Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479

Record changed: 2019-12-10


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Bruker (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Berlin Partner Network in German Capital Region 650x80px

» top